Sanofi (SNY) Return on Sales [ROS] (2009 - 2026)
Sanofi (SNY) posted Return on Sales [ROS] of 9.03% for the quarter ended Jun 30, 2026, down 5.71 percentage points from 14.74% a year earlier and down 11.15 percentage points from the prior quarter.
Sanofi (SNY) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Sanofi was 6.98%, down 13.45 percentage points year-over-year; for the year ended Dec 31, 2025, it was 14.54%, down 3.11 percentage points from the prior year.
- Annual Return on Sales [ROS] has declined for three consecutive years, with a five-year change of -24.62 percentage points (years ended Dec 2020 to Dec 2025).
- In prior years, Sanofi's Return on Sales [ROS] was 17.65% in the year ended Dec 31, 2024 (-0.75 pp), 18.40% in the year ended Dec 31, 2023 (-8.59 pp), 26.99% in the year ended Dec 31, 2022 (+5.47 pp) and 21.52% in the year ended Dec 31, 2021 (-17.64 pp).
- Quarterly Return on Sales [ROS] has run from a low of 8.30% in the quarter ended Dec 31, 2025 to a high of 122.84% in the quarter ended Dec 31, 2023 over five years.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last five quarters, with an average year-over-year change of -14.93 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was the quarter ended Dec 31, 2023, with a gain of 111.94 percentage points; the weakest was the quarter ended Dec 31, 2021, with a drop of 143.10 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 20.18% (quarter ended Mar 31, 2026), 8.30% (quarter ended Dec 31, 2025) and 22.84% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Sanofi | 48.68 Bn | 15.46 Bn | 10.79 Bn | 9.03% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.03% |
| Mar 31, 2026 | 20.18% |
| Dec 31, 2025 | 8.30% |
| Sep 30, 2025 | 22.84% |
| Jun 30, 2025 | 14.74% |
| Mar 31, 2025 | 23.09% |
| Dec 31, 2024 | 8.91% |
| Sep 30, 2024 | 29.11% |
| Jun 30, 2024 | 16.25% |
| Mar 31, 2024 | 13.84% |
| Dec 31, 2023 | 122.84% |
| Sep 30, 2023 | 26.84% |
| Jun 30, 2023 | 18.66% |
| Mar 31, 2023 | 24.10% |
| Dec 31, 2022 | 10.90% |
| Sep 30, 2022 | 21.82% |
| Jun 30, 2022 | 14.16% |
| Mar 31, 2022 | 24.78% |
| Dec 31, 2021 | 14.75% |
| Sep 30, 2021 | 29.06% |
Sanofi Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();